Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Garcia-Carbonero R, Benavent M, Jimenez-Fonseca P, Alonso-Gordoa T, Teulé A, Custodio A, Tafuto S, La Casta A, Spada F, López C, Ibrahim T, Iranzo V, García-Alfonso P, González-Flores E, Villanueva Silva MJ, Grande E, Panzuto F, Crespo G, Navarro M, Castellano D, Hernando J, Morales-Herrero R, Iglesias Álvarez G, Soldevilla B, Capdevila J

Open source

DOI: 10.1200/jco-25-01808
Published: 2026 Mar 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-01808,
  title = {Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).},
  author = {Garcia-Carbonero R and Benavent M and Jimenez-Fonseca P and Alonso-Gordoa T and Teulé A and Custodio A and Tafuto S and La Casta A and Spada F and López C and Ibrahim T and Iranzo V and García-Alfonso P and González-Flores E and Villanueva Silva MJ and Grande E and Panzuto F and Crespo G and Navarro M and Castellano D and Hernando J and Morales-Herrero R and Iglesias Álvarez G and Soldevilla B and Capdevila J},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-01808},
  url = {https://doi.org/10.1200/jco-25-01808}
}

RIS

TY  - JOUR
TI  - Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).
AU  - Garcia-Carbonero R
AU  - Benavent M
AU  - Jimenez-Fonseca P
AU  - Alonso-Gordoa T
AU  - Teulé A
AU  - Custodio A
AU  - Tafuto S
AU  - La Casta A
AU  - Spada F
AU  - López C
AU  - Ibrahim T
AU  - Iranzo V
AU  - García-Alfonso P
AU  - González-Flores E
AU  - Villanueva Silva MJ
AU  - Grande E
AU  - Panzuto F
AU  - Crespo G
AU  - Navarro M
AU  - Castellano D
AU  - Hernando J
AU  - Morales-Herrero R
AU  - Iglesias Álvarez G
AU  - Soldevilla B
AU  - Capdevila J
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-01808
UR  - https://doi.org/10.1200/jco-25-01808
ER  -

APA

R, G., M, B., P, J., T, A., A, T., A, C., S, T., A, L. C., F, S., C, L., T, I., V, I., P, G., E, G., MJ, V. S., E, G., F, P., G, C., M, N., D, C., J, H., R, M., G, I. Á., B, S., & J, C. (2026). Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-01808

Source records

pubmed · retrieved 2026-09-26T19:13:19.229Z